top of page
Talal Dahhan

Talal Dahhan


Assistant Professor of Medicine

Pulmonary, Allergy, and Critical Care Medicine

Center for Pulmonary Vascular Disease, DUMC 102351, Durham, NC 27710DUMC 102351 - 330 Trent Dr, Durham, NC 27710

(919) 668-0325

An Internist, Pulmonologist and Critical Care Medicine physician with great interest in diagnosis and management of pulmonary vascular disease, as well as innovations in critical care curricular designs and graduate medical education.


Pulmonary Diseases and Critical Care Medicine Fellowship, Medicine - Duke University School of MedicineInternal Medicine Residency, Medicine - Duke University School of MedicineM.D. 2003 - King Saud University (Saudi Arabia)


Retrospective and prospective international EKoSoNic® registry Of the treatment and Clinical OUTcomes of patients with Pulmonary Embolism awarded by BTG International Inc 2018 - 2023Photoacoustic-Imaging-Guided Intravascular Sonothrombolysis awarded by North Carolina State University 2019 - 2021US CTEPH Registry awarded by University of California - San Diego 2015 - 2020DS1040-B-U107: Phase 1B, Assess the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of DS-1040B when added to standard of care in subjects with submassive pulmonary embolism awarded by Daiichi Sankyo Inc 2017 - 2019Population-based Surveillance And Ourcomes of Venous Thromboembolism awarded by Centers for Disease Control and Prevention 2015 - 2017


Kussin, Peter S., and Talal Dahhan. “Physicians Should Not Offer to Pray With Patients in the ICU.Chest 162, no. 3 (September 2022): e151., Waleed, Mohammed Alshahrani, Fayez Alshamsi, Ohoud Aljuhani, Khalid Eljaaly, Samaher Hashim, Rakan Alqahtani, et al. “The Saudi Critical Care Society practice guidelines on the management of COVID-19 in the ICU: Therapy section.J Infect Public Health 15, no. 1 (January 2022): 142–51., Marwa, Ahmed M. Kamel, Mohammed Bawazeer, Khalid Maghrabi, Abid Butt, Talal Dahhan, Eiad Kseibi, et al. “Clinical characteristics and outcomes of critically ill mechanically ventilated COVID-19 patients receiving interleukin-6 receptor antagonists and corticosteroid therapy: a preliminary report from a multinational registry.Eur J Med Res 26, no. 1 (October 2, 2021): 117., Kishan S., Sean Doerfler, Nicholas Shelburne, Karla Kennedy, Jordan Whitson, Talal Dahhan, Terry Fortin, and Sudarshan Rajagopal. “Experience in Transitioning From Parenteral Prostacyclins to Selexipag in Pulmonary Arterial Hypertension.J Cardiovasc Pharmacol 75, no. 4 (April 2020): 299–304., Tara, Alexander E. Sullivan, Tracy Truong, Manesh R. Patel, Olamiji Sofela, Cynthia L. Green, Talal Dahhan, and W Schuyler Jones. “Identification, diagnosis, treatment, and in-hospital outcomes of acute pulmonary embolism: Results from a single integrated health system.Am Heart J 216 (October 2019): 136–42., Katherine, Jennifer Schultheis, Doug Raiff, and Talal Dahhan. “Evaluation of Rescue Thrombolysis in Cardiac Arrest Secondary to Suspected or Confirmed Pulmonary Embolism.Ann Pharmacother 53, no. 7 (July 2019): 711–15., Jordan D., Kathryn A. Stackhouse, Joanne Lee, Talal Dahhan, Kishan S. Parikh, and Richard A. Krasuski. “Outcomes of lung disease-associated pulmonary hypertension and impact of elevated pulmonary vascular resistance.Respir Med 150 (April 2019): 126–30., Kishan S., Talal Dahhan, Leigh Nicholl, Nicole Ruopp, Gina-Maria Pomann, Terry Fortin, Victor F. Tapson, and Sudarshan Rajagopal. “Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension.Sci Rep 9, no. 1 (March 11, 2019): 4061., Talal, Fawaz Alenezi, Zainab Samad, and Sudarshan Rajagopal. “Echocardiography in the Risk Assessment of Acute Pulmonary Embolism.Semin Respir Crit Care Med 38, no. 1 (February 2017): 18–28., Talal, Irfan Siddiqui, Victor F. Tapson, Eric J. Velazquez, Stephanie Sun, Clemontina A. Davenport, Zainab Samad, and Sudarshan Rajagopal. “Clinical and echocardiographic predictors of mortality in acute pulmonary embolism.Cardiovasc Ultrasound 14, no. 1 (October 28, 2016): 44.

bottom of page